Implantable devices for the treatment of cardiac arrhythmias.

R. M. Luceri, Agustin Castellanos, Robert J Myerburg

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The development of implantable devices for the treatment of tachyarrhythmias has resulted in additional therapeutic choices for the affected patients. Technologic advances now permit one to choose from a wide variety of devices capable of intervening automatically in the presence of supraventricular or ventricular arrhythmias. Although all methods remain in the investigational stage at this time, sufficient evidence has been gathered to support the efficacy of certain devices in the presence of various arrhythmias. Pacemaker-energy pulses may be delivered in various sequences to interrupt re-entrant rhythms, and their reproducible success can be effectively demonstrated in the electrophysiology laboratory. Cardioverting and defibrillating devices are capable of recognizing and successfully interrupting malignant ventricular arrhythmias. The automatic defibrillator has already been reported to reduce 1-year arrhythmic mortality in high-risk patients. Although still in the infant stages of development, the continuing advances in device technology suggest that their future applications are indeed promising.

Original languageEnglish
Pages (from-to)113-122
Number of pages10
JournalCardiology Clinics
Volume3
Issue number1
StatePublished - Feb 1 1985
Externally publishedYes

Fingerprint

Cardiac Arrhythmias
Equipment and Supplies
Therapeutics
Defibrillators
Electrophysiology
Child Development
Tachycardia
Technology
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Implantable devices for the treatment of cardiac arrhythmias. / Luceri, R. M.; Castellanos, Agustin; Myerburg, Robert J.

In: Cardiology Clinics, Vol. 3, No. 1, 01.02.1985, p. 113-122.

Research output: Contribution to journalArticle

Luceri, RM, Castellanos, A & Myerburg, RJ 1985, 'Implantable devices for the treatment of cardiac arrhythmias.', Cardiology Clinics, vol. 3, no. 1, pp. 113-122.
Luceri, R. M. ; Castellanos, Agustin ; Myerburg, Robert J. / Implantable devices for the treatment of cardiac arrhythmias. In: Cardiology Clinics. 1985 ; Vol. 3, No. 1. pp. 113-122.
@article{229846c8826145c5be5b6250306c2e1a,
title = "Implantable devices for the treatment of cardiac arrhythmias.",
abstract = "The development of implantable devices for the treatment of tachyarrhythmias has resulted in additional therapeutic choices for the affected patients. Technologic advances now permit one to choose from a wide variety of devices capable of intervening automatically in the presence of supraventricular or ventricular arrhythmias. Although all methods remain in the investigational stage at this time, sufficient evidence has been gathered to support the efficacy of certain devices in the presence of various arrhythmias. Pacemaker-energy pulses may be delivered in various sequences to interrupt re-entrant rhythms, and their reproducible success can be effectively demonstrated in the electrophysiology laboratory. Cardioverting and defibrillating devices are capable of recognizing and successfully interrupting malignant ventricular arrhythmias. The automatic defibrillator has already been reported to reduce 1-year arrhythmic mortality in high-risk patients. Although still in the infant stages of development, the continuing advances in device technology suggest that their future applications are indeed promising.",
author = "Luceri, {R. M.} and Agustin Castellanos and Myerburg, {Robert J}",
year = "1985",
month = "2",
day = "1",
language = "English",
volume = "3",
pages = "113--122",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Implantable devices for the treatment of cardiac arrhythmias.

AU - Luceri, R. M.

AU - Castellanos, Agustin

AU - Myerburg, Robert J

PY - 1985/2/1

Y1 - 1985/2/1

N2 - The development of implantable devices for the treatment of tachyarrhythmias has resulted in additional therapeutic choices for the affected patients. Technologic advances now permit one to choose from a wide variety of devices capable of intervening automatically in the presence of supraventricular or ventricular arrhythmias. Although all methods remain in the investigational stage at this time, sufficient evidence has been gathered to support the efficacy of certain devices in the presence of various arrhythmias. Pacemaker-energy pulses may be delivered in various sequences to interrupt re-entrant rhythms, and their reproducible success can be effectively demonstrated in the electrophysiology laboratory. Cardioverting and defibrillating devices are capable of recognizing and successfully interrupting malignant ventricular arrhythmias. The automatic defibrillator has already been reported to reduce 1-year arrhythmic mortality in high-risk patients. Although still in the infant stages of development, the continuing advances in device technology suggest that their future applications are indeed promising.

AB - The development of implantable devices for the treatment of tachyarrhythmias has resulted in additional therapeutic choices for the affected patients. Technologic advances now permit one to choose from a wide variety of devices capable of intervening automatically in the presence of supraventricular or ventricular arrhythmias. Although all methods remain in the investigational stage at this time, sufficient evidence has been gathered to support the efficacy of certain devices in the presence of various arrhythmias. Pacemaker-energy pulses may be delivered in various sequences to interrupt re-entrant rhythms, and their reproducible success can be effectively demonstrated in the electrophysiology laboratory. Cardioverting and defibrillating devices are capable of recognizing and successfully interrupting malignant ventricular arrhythmias. The automatic defibrillator has already been reported to reduce 1-year arrhythmic mortality in high-risk patients. Although still in the infant stages of development, the continuing advances in device technology suggest that their future applications are indeed promising.

UR - http://www.scopus.com/inward/record.url?scp=0022014955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022014955&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 113

EP - 122

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

IS - 1

ER -